Two US scientists awarded Balzan Prize for cancer research

September 11, 2017 by Colleen Barry
Salvatore Veca attends a press conference to present a 2017 Balzan's prize edition, in Milan, Italy, Monday, Sept. 11, 2017. James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington School of Medicine were announced Monday as winners of the 750,000 Swiss franc (660,000 euro, $790,000) prize. They were cited for work that has helped use antibody treatments that has increased the survival of patients with metastic melanoma. (AP Photo/Antonio Calanni)

Two U.S. scientists whose work has contributed to creating immunological treatments for cancer are among the winners of this year's Balzan Prizes, announced Monday, recognizing scholarly and scientific achievements.

James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington University School of Medicine were cited for their work on antibody treatments that has increased the survival of patients with metastatic melanoma.

The Balzan Foundation awards two prizes in the sciences and two in the humanities each year, rotating specialties to highlight new or emerging areas of research and sustain fields that might be overlooked elsewhere. Recipients receive 750,000 Swiss francs ($790,000), half of which must be used for research, preferably by young scholars or scientists.

Nobel Prize-winner Jules Hoffman, a presenter of the awards, said the work focusing on using the immune system to fight cancer, expanding from the traditional treatments of removal, radiation and chemotherapy, has already had success in 25 to 30 percent of melanoma patients in a study who had previously gone through the traditional battery of treatments. It is now being developed for small cell lung cancer and rectal cancer.

Other winners are:

—Belgian astrophysicist Michael Gillon for his work that has helped map new solar systems from the comfort of planet Earth, using robotic telescopes instead of much more costly satellites.

Thomas Maissen speaks to journalists during a press conference to present a 2017 Balzan's prize edition, in Milan, Italy, Monday, Sept. 11, 2017. James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington School of Medicine were announced Monday as winners of the 750,000 Swiss franc (660,000 euro, $790,000) prize. They were cited for work that has helped use antibody treatments that has increased the survival of patients with metastic melanoma. (AP Photo/Antonio Calanni)

—Germans Aleida and Jan Assmann, a married couple recognized for their work presenting collective memory "as a requirement for the formation of the identity of religious and political communities."

—Indian economist Bina Agarwal, a professor at the University of Manchester, recognized in the gender studies category for her "heroic" work studying women's contributions to agriculture in India.

—This year, the Balzan Foundation also awarded a fifth prize, in international relations, which was deferred from last year after the committee failed to reach agreement on a winner. It went to Robert O. Keohane of the Woodrow Wilson School at Princeton University, best known for his influential 1984 book "After Hegemony: Cooperation and Discord in the World Political Economy."

Prizes will be awarded in Bern, Switzerland, on Nov. 17.

Explore further: 1 Japanese, 2 Americans win Crafoord science prize

Related Stories

1 Japanese, 2 Americans win Crafoord science prize

January 12, 2017
A Japanese and two American scientists have been awarded the 2017 Crafoord Prize for fundamental discoveries in immune regulation.

Recommended for you

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

One in four U.S. seniors with cancer has had it before

November 22, 2017
(HealthDay)—For a quarter of American seniors, a cancer diagnosis signals the return of an old foe, new research shows.

Combination immunotherapy targets cancer resistance

November 22, 2017
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.